Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003442811> ?p ?o ?g. }
- W2003442811 endingPage "589" @default.
- W2003442811 startingPage "581" @default.
- W2003442811 abstract "Objective Our objective was to investigate the association between the −344C/T or A6547G polymorphism of the aldosterone synthase gene and the blood pressure response to angiotensin-converting enzyme inhibitors in a hypertensive cohort. Methods After a 2-week single-blind placebo run-in period, either benazepril or imidapril was administered for 6 weeks to 509 patients with mild to moderate essential hypertension. Polymerase chain reaction combined with restriction enzyme digestion was used to detect the 2 polymorphisms. The achieved changes in systolic and diastolic blood pressure were analyzed for their association with genotypes at the aldosterone synthase gene loci. Results Regarding the −344C/T polymorphism, we observed the CC genotype in 53 patients (10.4%), the CT genotype in 204 (40.1%), and the TT genotype in 252 (49.5%). After 6 weeks of treatment, the reductions in diastolic blood pressure were significantly greater in patients carrying the TT or CT genotype compared with those carrying the CC genotype (9.1 ± 7.0 mm Hg or 8.9 ± 7.0 mm Hg versus 5.1 ± 7.3 mm Hg, respectively; P=.001, ANOVA). Regarding the A6547G polymorphism, we observed the AA genotype in 19 patients (3.7%), the AG genotype in 184 (36.2%), and the GG genotype in 306 (60.1%). There were no significant differences in the blood pressure reductions after treatment among the 3 genotype groups, and there was no interaction between it and the −344C/T polymorphism. Stepwise multiple regression analysis showed that the significant predictors of diastolic blood pressure reduction at 6 weeks were baseline diastolic blood pressure (P < .001), −344C/T genotype (P=.007), and sex (P=.033). Conclusions The −344C/T variant, but not the A6547G variant, of the aldosterone synthase gene may be a determinant of the blood pressure response to angiotensin-converting enzyme inhibitors in hypertensive patients. Clinical Pharmacology & Therapeutics (2006) 79, 581–589; doi: 10.1016/j.clpt.2006.02.007" @default.
- W2003442811 created "2016-06-24" @default.
- W2003442811 creator A5022000477 @default.
- W2003442811 creator A5030629550 @default.
- W2003442811 creator A5031938818 @default.
- W2003442811 creator A5055229683 @default.
- W2003442811 creator A5064211059 @default.
- W2003442811 creator A5085370636 @default.
- W2003442811 date "2006-06-01" @default.
- W2003442811 modified "2023-10-14" @default.
- W2003442811 title "Associations between CYP11B2 gene polymorphisms and the response to angiotensin-converting enzyme inhibitors" @default.
- W2003442811 cites W1963548500 @default.
- W2003442811 cites W1971786368 @default.
- W2003442811 cites W1979069430 @default.
- W2003442811 cites W1982542904 @default.
- W2003442811 cites W1984312453 @default.
- W2003442811 cites W1984828684 @default.
- W2003442811 cites W1985770217 @default.
- W2003442811 cites W1987391951 @default.
- W2003442811 cites W2019373325 @default.
- W2003442811 cites W2022293803 @default.
- W2003442811 cites W2031642214 @default.
- W2003442811 cites W2051232388 @default.
- W2003442811 cites W2066598157 @default.
- W2003442811 cites W2067792022 @default.
- W2003442811 cites W2069169326 @default.
- W2003442811 cites W2100537111 @default.
- W2003442811 cites W2116433590 @default.
- W2003442811 cites W2123978721 @default.
- W2003442811 cites W2135207001 @default.
- W2003442811 cites W2145366887 @default.
- W2003442811 cites W2153471894 @default.
- W2003442811 cites W2154375739 @default.
- W2003442811 cites W2161212879 @default.
- W2003442811 cites W2163757009 @default.
- W2003442811 cites W2335083369 @default.
- W2003442811 cites W2995201542 @default.
- W2003442811 doi "https://doi.org/10.1016/j.clpt.2006.02.007" @default.
- W2003442811 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16765146" @default.
- W2003442811 hasPublicationYear "2006" @default.
- W2003442811 type Work @default.
- W2003442811 sameAs 2003442811 @default.
- W2003442811 citedByCount "21" @default.
- W2003442811 countsByYear W20034428112012 @default.
- W2003442811 countsByYear W20034428112013 @default.
- W2003442811 countsByYear W20034428112014 @default.
- W2003442811 countsByYear W20034428112016 @default.
- W2003442811 countsByYear W20034428112019 @default.
- W2003442811 crossrefType "journal-article" @default.
- W2003442811 hasAuthorship W2003442811A5022000477 @default.
- W2003442811 hasAuthorship W2003442811A5030629550 @default.
- W2003442811 hasAuthorship W2003442811A5031938818 @default.
- W2003442811 hasAuthorship W2003442811A5055229683 @default.
- W2003442811 hasAuthorship W2003442811A5064211059 @default.
- W2003442811 hasAuthorship W2003442811A5085370636 @default.
- W2003442811 hasConcept C104317684 @default.
- W2003442811 hasConcept C126322002 @default.
- W2003442811 hasConcept C134018914 @default.
- W2003442811 hasConcept C135763542 @default.
- W2003442811 hasConcept C149737253 @default.
- W2003442811 hasConcept C198710026 @default.
- W2003442811 hasConcept C27016395 @default.
- W2003442811 hasConcept C2777363265 @default.
- W2003442811 hasConcept C2778525890 @default.
- W2003442811 hasConcept C2780249997 @default.
- W2003442811 hasConcept C54355233 @default.
- W2003442811 hasConcept C71924100 @default.
- W2003442811 hasConcept C76252995 @default.
- W2003442811 hasConcept C84393581 @default.
- W2003442811 hasConcept C86803240 @default.
- W2003442811 hasConceptScore W2003442811C104317684 @default.
- W2003442811 hasConceptScore W2003442811C126322002 @default.
- W2003442811 hasConceptScore W2003442811C134018914 @default.
- W2003442811 hasConceptScore W2003442811C135763542 @default.
- W2003442811 hasConceptScore W2003442811C149737253 @default.
- W2003442811 hasConceptScore W2003442811C198710026 @default.
- W2003442811 hasConceptScore W2003442811C27016395 @default.
- W2003442811 hasConceptScore W2003442811C2777363265 @default.
- W2003442811 hasConceptScore W2003442811C2778525890 @default.
- W2003442811 hasConceptScore W2003442811C2780249997 @default.
- W2003442811 hasConceptScore W2003442811C54355233 @default.
- W2003442811 hasConceptScore W2003442811C71924100 @default.
- W2003442811 hasConceptScore W2003442811C76252995 @default.
- W2003442811 hasConceptScore W2003442811C84393581 @default.
- W2003442811 hasConceptScore W2003442811C86803240 @default.
- W2003442811 hasIssue "6" @default.
- W2003442811 hasLocation W20034428111 @default.
- W2003442811 hasLocation W20034428112 @default.
- W2003442811 hasOpenAccess W2003442811 @default.
- W2003442811 hasPrimaryLocation W20034428111 @default.
- W2003442811 hasRelatedWork W1974641745 @default.
- W2003442811 hasRelatedWork W1980328605 @default.
- W2003442811 hasRelatedWork W2016647631 @default.
- W2003442811 hasRelatedWork W2077998387 @default.
- W2003442811 hasRelatedWork W2101834938 @default.
- W2003442811 hasRelatedWork W2105380188 @default.
- W2003442811 hasRelatedWork W2126797993 @default.
- W2003442811 hasRelatedWork W2516746587 @default.